Community Research and Development Information Service - CORDIS

Horizon 2020 project information and now also report summaries are available on CORDIS. All H2020 projects can be downloaded from the EU Open Data Portal .

My refinements


Download results of this page


Refine by:

Country

Austria (3)
Belgium (11)
Burkina Faso (1)
Czech Republic (2)
Denmark (6)
Finland (5)
France (13)
Germany (19)
Ireland (3)
Italy (13)
Luxembourg (3)
Netherlands (17)
Norway (1)
Poland (1)
Senegal (1)
Slovenia (2)
Spain (8)
Sweden (9)
Switzerland (8)
United Kingdom (21)
United States (5)

Content Type

Project (21)
Programme (35)

Language

English (54)

Advanced search

Results 1 - 10 of 56
Results/page:
12 3 4 5 6 > 
Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen
ID: 115854
Start date: 2014-12-01, End date: 2019-11-30
The overall aim of the EBOVAC programme is to assess the safety and efficacy/effectiveness, if feasible, of a novel prime-boost prophylactic vaccine regimen against Ebola Virus Disease (EVD), which has been 100% effective in preclinical studies. This will be done via phase I...
Programme: H2020-EU.3.1.7.13.
Record Number: 209452
Last updated on: 2017-03-27
Remote Assessment of Disease and Relapse in Central Nervous System Disorders
ID: 115902
Start date: 2016-04-01, End date: 2021-03-31
Background: Long term conditions require monitoring of patients, traditionally conducted in the clinic, to monitor treatment effects, adverse events and disease course. This can be inefficient and cumbersome – clinic visits may be too infrequent to identify individuals at...
Programme: H2020-EU.3.1.7.13.
Record Number: 209453
Last updated on: 2017-05-23
Objectives (restricted scope is expected for Phase 1) to establish multiple key regional project sites (demonstration sites) across Europe to identify and test models of efficient earlier identification of mild AD dementia and prodromal AD patients, and awareness of AD risk;...
Record Number: 702428
The scope is to identify critical mechanism(s) by which ApoE4 leads to the development of AD to build the basis for future development of treatment approaches and supporting biomarkers for ApoE4-positive patients. Research will seek to understand how ApoE4 leads to AD and not...
Record Number: 702427
The scope is to understand:The utility of β-amyloid imaging in the context of other biomarkers and diagnostic tests in current clinical practise in AD.The use of β-amyloid imaging in the enrichment of preclinical/pre-dementia clinical trial populations and its incorporation...
Record Number: 702426
The objectives are to identify and validate candidate biomarkers and/or biomarker panels from existing longitudinal databases. Enhance the understanding of key driver pathways that accelerate progression of DKD, as well as pathways that enable & drive the pathogenesis of...
Record Number: 702422
To identify druggable points of interaction in the TREM2 and CD33-signalling pathways to modulate microglial/macrophage function for the treatment of AD, focusing on in vitro, in vivo methodologies using comprehensive analysis tools and pathway/systems biology approaches to...
Record Number: 702425
To establish recommendations with the view of supporting the development of guidance for industry, regulators and health technology assessment (HTA) bodies on how and when in the product life-cycle to consider patient perspectives on benefits and risks of medicinal products to...
Record Number: 702420
[PROGRAMME]
Record Number: 665324
[PROGRAMME]
Record Number: 665323
12 3 4 5 6 > 
List retrieved on: 2017-07-27
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top